Brief: Eckert & Ziegler Prepares Split-Off Of Clinical Assets

Eckert & Ziegler SE

20/10/2023 14:23

Oct 20 (Reuters) - ECKERT & ZIEGLER STRAHLEN UND
MEDIZINTECHNIK AG  EUZG.DE :
    * ECKERT & ZIEGLER FOCUSES ON CORE COMPETENCE AND PREPARES
SPLIT-OFF OF CLINICAL ASSETS
    * FORECAST FOR FINANCIAL YEAR 2023 REMAINS UNCHANGED.
    * INTENDS TO POOL ITS FINANCIAL RESOURCES TO EXPAND ITS
GLOBAL
MANUFACTURING CAPACITIES
    * SUPERVISORY BOARD OF ECKERT & ZIEGLER AG TODAY HAS GIVEN
ITS
APPROVAL TO EXECUTIVE BOARD TO EXAMINE AND PREPARE A SPLIT-OFF
OF UP TO 100 PERCENT OF SHARES IN PENTIXAPHARM AG
    * CONCENTRATING ON ITS CORE COMPETENCIES IN ORDER TO FURTHER
EXPAND ITS POSITION AS A LEADING SUPPLIER OF RADIOISOTOPES FOR
PRODUCTION OF RADIOPHARMACEUTICALS.
    * FORECAST FOR FINANCIAL YEAR 2023 REMAINS UNCHANGED
    * IN ACCORDANCE WITH IFRS 5, EXECUTIVE BOARD WILL REPORT PTX
AS A
DISCONTINUED OPERATION IN 2023 ANNUAL FINANCIAL STATEMENTS

Source text for Eikon:  ID:nEQ5Qyc63a 
Further company coverage:  EUZG.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))